This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Risk of fatal ICH with alteplase for stroke (id = "example-stroke-alteplase-fatalICH")
<?xml version="1.0" encoding="UTF-8"?> <Evidence xmlns="http://hl7.org/fhir"> <id value="example-stroke-alteplase-fatalICH"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> "Risk of fatal ICH with alteplase for stroke" is a univariate risk estimate. </p> </div> </text> <url value="Evidence/example-stroke-alteplase-fatalICH"/> <title value="Risk of fatal ICH with alteplase for stroke"/> <status value="draft"/> <relatedArtifact> <type value="citation"/> <label value="Emberson 2014"/> <display value="Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials."/> <citation value="Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063"/> <url value="https://doi.org/10.1016/S0140-6736(14)60584-5"/> </relatedArtifact> <description value="2.7% incidence of fatal intracranial hemorrhage within 7 days with alteplase in patients with acute ischemic stroke"/> <variableDefinition> <variableRole> <coding> <system value="http://terminology.hl7.org/CodeSystem/variable-role"/> <code value="population"/> <display value="population"/> </coding> </variableRole> <observed> <reference value="Group/AcuteIschemicStroke"/> <type value="Group"/> <display value="adults with acute ischemic stroke"/> </observed> <intended> <reference value="Group/AcuteIschemicStroke"/> <type value="Group"/> <display value="adults with acute ischemic stroke"/> </intended> </variableDefinition> <variableDefinition> <variableRole> <coding> <system value="http://terminology.hl7.org/CodeSystem/variable-role"/> <code value="population"/> <display value="population"/> </coding> </variableRole> <observed> <reference value="Group/Emberson-2014-IPD-MA-Alteplase-Cohort"/> <type value="Group"/> <display value="Emberson 2014 IPD-MA Alteplase Cohort"/> </observed> <intended> <reference value="Group/AcuteIschemicStrokeTreatedWithAlteplase"/> <type value="Group"/> <display value="adults with acute ischemic stroke treated with alteplase"/> </intended> </variableDefinition> <variableDefinition> <variableRole> <coding> <system value="http://terminology.hl7.org/CodeSystem/variable-role"/> <code value="measuredVariable"/> <display value="measured variable"/> </coding> </variableRole> <observed> <reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/> <type value="EvidenceVariable"/> <display value="fatal ICH"/> </observed> <intended> <reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/> <type value="EvidenceVariable"/> <display value="fatal ICH"/> </intended> </variableDefinition> <synthesisType> <coding> <system value="http://terminology.hl7.org/CodeSystem/synthesis-type"/> <code value="IPD-MA"/> <display value="individual patient data meta-analysis"/> </coding> </synthesisType> <studyType> <coding> <system value="http://terminology.hl7.org/CodeSystem/study-type"/> <code value="RCT"/> <display value="randomized trial"/> </coding> </studyType> <statistic> <statisticType> <coding> <system value="http://terminology.hl7.org/CodeSystem/statistic-type"/> <code value="C44256"/> <display value="Proportion"/> </coding> </statisticType> <quantity> <value value="0.026835741669"/> </quantity> <numberOfEvents value="91"/> <sampleSize> <numberOfStudies value="9"/> <numberOfParticipants value="3391"/> </sampleSize> </statistic> </Evidence>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.